144060-53-7 Febuxostat About
Elevate therapeutic excellence with our highlighted 144060-53-7 Febuxostat, an ephemeral yet unassailable API for unmatched pharmaceutical performance. Crafted to comply with exacting standard tests, each batch boasts a redoubtable purity over 99% (HPLC), and a matchless safety profile adhering to ICH and pharmacopeia limits for solvents and microbes. This pharmaceutical-grade, odorless powder is secured in robust HDPE drums with double inner polyethylene bags, ensuring unrivaled protection. Non-poisonous and fit for gout therapy, Febuxostat's composition stands as the unyielding choice for dependable uric acid management.
Commercial Uses and Site of Application for Febuxostat (CAS 144060-53-7)
Febuxostat, known under CAS No. 144060-53-7, is an active pharmaceutical ingredient (API) primarily applied in the management of gout by lowering uric acid levels. Commercially, this matchless compound is utilized across leading pharmaceutical industries, suitable for both branded and generic medications. Its application site is specific to the pharmaceutical manufacturing sector, where precision and purity are paramount for therapeutic efficacy in gout patients. Designed for industrial formulation, Febuxostat ensures superior outcomes in uric acid control therapies.
Febuxostat Packaging, Supply, and Market Value Information
Packaging details for Febuxostat include HDPE drums with double inner polyethylene bags, safeguarding the product through every stage of handover. The supply ability is robust, reflecting high manufacturing standards and consistent market demand. Delivery from China's prominent exporters, manufacturers, suppliers, and traders is facilitated from major FOB ports. The list price and market value of Febuxostat are set by industry benchmarks, ensuring competitive access to a pure, stable, and pharmaceutical-grade API for global partners.
FAQ's of 144060-53-7 Febuxostat:
Q: How should Febuxostat (CAS 144060-53-7) be stored to maintain its efficacy?
A: Febuxostat should be stored in a tightly closed container, protected from light and moisture, in order to maintain its stability and efficacy throughout its two-year shelf life.
Q: What is the typical usage of Febuxostat in pharmaceutical manufacturing?
A: Febuxostat is used as an active pharmaceutical ingredient (API) in the formulation of medicines that lower blood uric acid levels, particularly for patients diagnosed with gout.
Q: When is Febuxostat recommended for use in therapy?
A: Febuxostat is recommended when patients have elevated uric acid levels, commonly associated with gout, and require pharmaceutical intervention to manage and lower these levels efficiently.
Q: Where does Febuxostat see primary application within the pharmaceutical industry?
A: Its primary application is in industrial-scale drug manufacturing facilities that produce prescription gout medications.
Q: What are the benefits of Febuxostat's packaging and purity standards?
A: Febuxostat is packaged in HDPE drums with double inner bags, ensuring integrity during transport and storage. With a purity greater than 99% and compliance with strict ICH and pharmacopeia guidelines, it provides consistent and dependable performance in formulation processes.
Q: How is the handover and supply of Febuxostat typically managed internationally?
A: International supply is managed via reputable exporters and traders in China, with handover occurring at major FOB ports, ensuring efficient and secure shipment to global partners.
Send Inquiry
Send Inquiry
Send Inquiry
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese